Trial ID or NCT#

NCT03836001

Status

recruiting iconRECRUITING

Purpose

To determine if Serlopitant (when taken by mouth) is safe and works on itch in patients aged 13 and above with EB.

Official Title

A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa

Eligibility Criteria

Ages Eligible for Study: Older than 13 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Albert Sean Chiou, MD, MBA
Albert Sean Chiou, MD, MBA
Dermatologist
Clinical Assistant Professor, Dermatology

Contact us to find out if this trial is right for you.

CONTACT

Clinical Trial Coordinator
(650) 721-7149